sk&f 97541 has been researched along with Disease Models, Animal in 7 studies
3-aminopropyl(methyl)phosphinic acid: structure given in first source; GABA-A receptor antagonist
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "It suppressed tonic phase of generalized seizures induced by pentetrazol in 7-, 12- and 18-day-old rats and increased their latency in 7- and 12-day-old animals." | 1.35 | Anticonvulsant action of GABA-B receptor agonist SKF97541 differs from that of baclofen. ( Mares, P, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Gawlińska, K | 1 |
| Jastrzębska, J | 1 |
| Gamberini, S | 1 |
| Gawliński, D | 1 |
| Pieniążek, R | 1 |
| Suder, A | 1 |
| Wydra, K | 1 |
| Frankowska, M | 2 |
| Dissel, S | 1 |
| Angadi, V | 1 |
| Kirszenblat, L | 1 |
| Suzuki, Y | 1 |
| Donlea, J | 1 |
| Klose, M | 1 |
| Koch, Z | 1 |
| English, D | 1 |
| Winsky-Sommerer, R | 1 |
| van Swinderen, B | 1 |
| Shaw, PJ | 1 |
| Fields, AM | 1 |
| Richards, TA | 1 |
| Felton, JA | 1 |
| Felton, SK | 1 |
| Bayer, EZ | 1 |
| Ibrahim, IN | 1 |
| Kaye, AD | 1 |
| Manev, H | 1 |
| Dimitrijevic, N | 1 |
| Filip, M | 1 |
| Mares, P | 1 |
7 other studies available for sk&f 97541 and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
The impact of GABA
Topics: Animals; Baclofen; Behavior, Addictive; Behavior, Animal; Brain; Central Nervous System Stimulants; | 2020 |
Sleep restores behavioral plasticity to Drosophila mutants.
Topics: Adenylyl Cyclases; Alzheimer Disease; Animals; Animals, Genetically Modified; Behavior, Animal; Dise | 2015 |
Analysis of responses to valerian root extract in the feline pulmonary vascular bed.
Topics: Acetylcholine; Animals; Arachidonic Acid; Bradykinin; Calcium Channel Agonists; Cats; Disease Models | 2003 |
Drosophila model for in vivo pharmacological analgesia research.
Topics: Analgesia; Animals; Avoidance Learning; Disease Models, Animal; Dose-Response Relationship, Drug; Dr | 2004 |
Effects of GABA(B) receptor agents on cocaine priming, discrete contextual cue and food induced relapses.
Topics: Animals; Baclofen; Behavior, Animal; Cocaine; Cocaine-Related Disorders; Conditioning, Operant; Cues | 2007 |
Anticonvulsant action of GABA-B receptor agonist SKF97541 differs from that of baclofen.
Topics: Age Factors; Animals; Anticonvulsants; Baclofen; Disease Models, Animal; Dose-Response Relationship, | 2008 |